What is ANI Pharmaceuticals's generics and other — D&A?

ANI Pharmaceuticals (ANIP) reported generics and other — D&A of $0 in Q1 2026.

What does generics and other — D&A mean?

Represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives specifically attributable to the generics segment. This metric is essential for understanding the capital intensity of the segment's manufacturing and intellectual property assets.

ANI Pharmaceuticals ANIP Generics and Other — D&A

Other segment segments

Rare Disease and Brands

$0—

Similar metrics at other companies

MDUOther — D&A

$0—

SIGOther — D&A

$100K0.0%

GNTXOther — D&A

$1.33M+63.4%

UNFAll Other Segments — D&A

$818K+6.9%

CEOther — D&A

$13M+30.0%

NKTRAll Other Segments — D&A

$121K-69.3%

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.88B+18.3%

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's generics and other — d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's generics and other — D&A?: ANI Pharmaceuticals (ANIP) reported generics and other — D&A of $0 in Q1 2026.
What does generics and other — D&A mean?: Represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives specifically attributable to the generics segment. This metric is essential for understanding the capital intensity of the segment's manufacturing and intellectual property assets.